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Abstract 
Background/Aims: The recent improvements of management of patients in pediatric 
intensive care units (PICU) are associated with improved outcome. However, this decrease in 
mortality is associated with an increased number of children with acute kidney injury (AKI), 
especially in patients with multiorgan failure. Methods: The report presents a retrospective 
analysis of 25 cases of AKI (assessed based on the pRIFLE criteria) in PICU within 7 years. 
Results: AKI was diagnosed in 1.24% of all hospitalized children. AKI percentage duration 
(as compared to the total hospitalization time) in the children who died vs. the survivors was 
79.55% vs. 46.19%, respectively (p<0.05). The mortality rate of AKI patients was 40% which was 
4.4-times higher as compared to the total mortality rate in PICU. The final cumulative survival 
ratio (FCSR) of patients meeting the oliguria criterion (which was met in 48% of AKI patients) 
was 37% vs. 49% in non-oliguric children. Averaged urine output values in the first week of 
hospitalization in the deceased vs. survivors were 1.49 vs. 2.57 ml/kg/h, respectively (p<0.05). 
Conclusions: Oliguria should not be considered as a sensitive parameter for AKI diagnosing 
in children below one year of age. A decreased mean urine output in the first week of PICU 
hospitalization (less than 1.4 ml/kg/h) should be considered as a poor prognostic factor. In 
many cases AKI was diagnosed too infrequently and too late.
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Introduction 
Commonly available, effective, but at the same time increasingly more aggressive 
therapeutic methods are associated with an increase the number of patients hospitalized 
in pediatric intensive care units (PICU). Furthermore, the risk of AKI associated with those 
medical procedures and of nephrotoxic medications may be increased. This phenomenon 
resulted to an increased number of patients with AKI, however, the precise incidence rate of 
this complication has been reported only in approximate values [1]. 
The majority of documented cases of AKI in pediatric patients described children 
who had already developed renal failure (stage F) and required renal replacement therapy 
(RRT) [2-5]. Nevertheless, the results of recent studies indicate that a low increase in serum 
creatinine (SCr), amounting only to 10%-24%, was positively correlated with duration 
of hospitalization and cost of treatment and was an independent factor of morbidity and 
mortality risk both in adult patients and in children [6, 7]. 
Material and Methods 
The objective of the present study was a retrospective analysis of AKI in PICU patients, taking into 
consideration epidemiology and prevalence of diagnosing this complication depending on the definition 
employed. Furthermore, a number of diagnostic parameters were meticulously evaluated as potential 
predictors of mortality. Data from such studies might be crucial for the development of an diagnostic-
therapeutic algorithm for AKI pediatric patients allowing an early identification of high risk groups. The 
early diagnosis of AKI will lead to immediate therapeutic interventions before the development of loss of 
renal function (stage L) or end stage renal disease (stage E) [1, 8, 9]. 
The study included 25 children (8 newborns, 8 infants, 9 older children) hospitalized in PICU of the 
University Children’s Hospital of Cracow, Poland in the period between January 1st, 2006 and December 
31st, 2012. The medical records of these patients featured the ICD10 N17 code (AKI). All children had 
bladder catheters and their hourly urine output (UO) was monitored.
In the present study, a change in the prevalence of AKI diagnosing depending on the employed definition 
of "zero point", which assessed the initial kidney function, was analyzed. In all patients, the diagnosis of AKI 
was established employing the pRIFLE scale criteria [10], with the initial values of SCr or eGFR determined 
by the following methods: 
I. In the newborn group, the “zero point” for the pRIFLE scale was determined based on SCr and eGFR 
(SCrN, eGFRN) values depending on gestational and chronological age [11, 12], 
II. In the infant group, the "zero point” for the pRIFLE scale was determined based on: 
1. SCr value calculated for age according to the following equation: SCr=(0.18 + 0.032 x age) x 88.4 
[13], 
2. minimum SCr value for age (6 μmol/l) [14], 
3. maximum SCr value for age of 1-23 months (23 μmol/l) [14], 
4. eGFR value calculated according to the one-marker formula developed by Pottel et al. [15] from the 
creatinine concentration value on the first or second day of hospitalization or up to 3 months before 
hospitalization. 
III. In the group of older children, the "zero point" for the pRIFLE scale was determined based on: 
1. SCr value calculated for age [13], 
2. minimum SCr value for age (6 μmol/l) [14], 
3. maximum SCr value for a given age (age/SCr: 1-6 years: 57 μmol/l; 7-12 years: 74 μmol/l; 
13-18 years: 100 μmol/l) [14], 
4. initial eGFR value determined at the 100 ml/min level. 
Additionally, in all the age groups, AKI was diagnosed based on the hourly UO value according to the 
pRIFLE scale. 
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The statistical description of the results and comparative analysis of their distribution were 
performed using respectively: the mean value, range, standard deviation, median value, first and third 
quartiles, t-Student test and – in view of the lack of certainty as to all the investigated groups meeting the 
assumptions of the t-Student test – the rank sum Wilcoxon test. In addition, the ROC curve analysis was 
performed, resulting in calculating the area under the curve and establishing the cut-off point, for which 
the following values were determined: the LR coefficient (at the same time constituting the odds ratio) as 
well as sensitivity and specificity. The survival analysis was performed using the Kaplan-Meier curves with 
the log-rank test, Cox-Mantel test and Gehan generalized Wilcoxon test. The significance of the difference 
between two-stage distributions was assessed by the one-sided Fisher’s exact test. The calculations were 
performed using the Matlab package (MATLAB and Statistics Toolbox Release 2013a, The MathWorks, Inc., 
Natick, Massachusetts, USA) and verified by the STATISTICA package (V. 10, StatSoft, Inc., www.statsoft.
com). The threshold value of p=0.05 was adopted while assessing statistical significance. 
Results 
The most common primary diagnoses established in the analyzed population of 
children with AKI were hemato-oncologic diseases; AKI with a nephrologic background 
was diagnosed in a single patient only. The most frequent coexisting diagnosis, secondary to 
the primary disease, was multiorgan failure (MOF). Nephrologic causes were noted in two 
cases only (i.e. autosomal recessive polycystic kidney disease as a primary diagnosis and one 
kidney necrosis accompanying necrotizing enterocolitis as coexisting diagnosis). Cardiac 
diseases were the most common primary causes of AKI in the group of newborns, while 
hemato-oncologic diseases predominated in the group of older children. Table 1 presents the 
primary and secondary diagnoses noted in the analyzed population. 
The mean duration of hospitalization in PICU of the child with AKI was 35 days, with 
newborns being hospitalized for the longest period and the duration of hospitalization 
decreasing in the older age groups (Figure 1). 
All the newborns and infants were on mechanical ventilatory support, while mechanical 
ventilation was required by 78% of the older children. The longest period of ventilatory 
support was required by the newborns, but in the analysis of the percentage of mechanical 
ventilation days vs. the entire hospitalization period in PICU, no significant differences were 
demonstrated between particular age groups. The majority of children required parenteral 
nutrition. Table 2 presents detailed clinical data of the children hospitalized in PICU. 
Nephrotoxic aminoglycosides were employed in two children only, with the mean 
treatment duration of 7 days. Vancomycin was also rarely administered. Loop diuretics 
were used in all the children; no difference was noted in the percentage of duration of loop 
diuretics administration vs. the entire hospitalization in PICU for particular age groups. 
The longest time of using dopaminergic medications, adrenaline and noradrenaline was 
observed in the group of newborns; there was a tendency towards shortening the duration 
of administration of the above pharmaceuticals in older age groups. ACE inhibitor (enalapril) 
was used in 9 patients (36%), including 4 newborns (50%), which was the consequence of 
the highest prevalence of cardiac diseases as the cause of AKI in this age group. One-half 
newborns required cardiac surgery which took place from 9-th to 18-th day of PICU stay. 
The mean minimum urine output in the investigated group of children was 0.82 ml/
kg/h, with the group of newborns demonstrating nonoliguric AKI (UO 1.19 ml/kg/h). The 
phenomenon of nonoliguric AKI in newborns was also confirmed by the analysis of the mean 
urine output in the first week of hospitalization, which in this age group equaled 2.65 ml/
kg/h (as compared to 1.4 ml/kg/h in the older children). The mean onset time of oliguria 
(defined as UO below 0.5 ml/kg/h/minimum 16 hours; pRIFLE stage I - injury) was on day 5 
of hospitalization. The mean time of determining creatinine concentration in PICU patients 
was day 2 of hospitalization. 
Stage F - failure - was noted in 84% of the investigated children, with the prevalence 
being 75% in newborns and infants and 100% in older children. The mean time of detect-
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employed method of determining the initial value of SCr or eGFR to be used in the pRIFLE 
scale in a given age group, the authors demonstrated that AKI could have been diagnosed in 
every case, regardless of the selected method of determining the "zero point". On the other 
hand, the criteria of the value of hourly urine output classified as oliguria (stage I according 
to pRIFLE; UO < 0.5 ml/kg/h/min.16 hours) – as the prerequisite of AKI diagnosis establish-
ment – were met by 12 (48%) of the children (25% of newborns, 50% of infants and 66.7% 
of older children). The data confirmed the observation of nonoliguric AKI in the population 
of newborns and infants. Table 4 presents particular methods of diagnosing AKI in the group 
of the analyzed children. 
Table 1. Prevalence and type of primary and secondary diagnoses in the studied 
pediatric population
ing stage I was day 
3 of hospitalization, 
while for stage F, 
the detection oc-
curred on day 4. 
Renal replace-
ment therapy (RRT) 
was required by 
one-half of the chil-
dren; the mean RRT 
duration was 11.4 
days (or 32.6% of 
the total hospitali-
zation in PICU). The 
most frequently 
employed methods 
were peritoneal di-
alysis (50%) and 
continuous dialysis 
techniques (25%). 
The mean du-
ration of AKI in the 
investigated group 
of children was 12.2 
days, what equaled 
60% of the total 
hospitalization time 
in PICU. The longest 
duration of AKI was 
noted in the group 
of newborns (20 
days), being equal 
to 50% of their hos-
pitalization time 
in PICU. Table 3 
presents a detailed 
characterization of 
kidney function in 
the analyzed popu-
lation. 
While analyz-
ing the prevalence 
of establishing the 
diagnosis of AKI 
depending on the 
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Table 2. Clinical characterization of the pediatric study population
Fig. 1. The median and interquartile 
range of the duration of hospitaliza-
tion in PICU depending on the age 
group. The whiskers indicate the 
whole range for each group.
Table 3. Detailed characterization of kidney function in the analyzed population of children
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Table 4. Methods of diagnosing AKI in the analyzed group of children
In the investigated group, 40% of the children died. The percentage of AKI duration 
vs. the total hospitalization time in PICU was significantly higher in the group of children 
with a negative outcome (79.77% vs. 46.19 %; p<0.05). The deceased children were younger 
compared to the survivors, however this difference was not statistically significant. 
Death, most commonly being a consequence of multiorgan failure (MOF; 6 cases of 
MOF in a group of 10 deceased children), usually secondary to hemato-oncologic diseases 
(5/10) occurred on day 19.4. The surviving children revealed the mean PICU hospitalization 
duration of 45.5 days, hence the resultant longer duration of RRT in this group of patients. 
These children predominantly suffered from cardiac diseases (7/15). 
With regard to the survival rate in MOF patients - death occurred in 6/14 (42,3%) 
patients with MOF and this incidence was higher (although not statistically significant than 
that of patients without MOF (4/11, 36%). 
All the deceased children required mechanical ventilatory support, which was 
employed practically during their entire hospitalization in PICU and was significantly longer 
with respect to the percentage of ventilatory support vs. the total hospitalization time in 
PICU than in the group of surviving children (p=0.001). Total parenteral nutrition (TPN) was 
employed in all the deceased children (mean time: 8.8 days) and in 80% of the surviving 
children (mean time: 13.67 days). No differences were noted in the frequency and duration of 
using dopaminergic medications between the group of deceased children and the survivors. 
A difference was observed only in the frequency of adrenaline and noradrenaline usage; the 
medications were employed twice as frequently in the group of the deceased children. 
Although the value of hourly UO is not a reliable marker when diagnosing AKI (especially 
in newborns and infants), nevertheless, its decreased value proved to be an indicator of a 
poor prognosis. In the group of the deceased children as compared to the surviving patients, 
not only was the mean minimum value of UO lower by half (0.52 vs. 1.00 ml/kg/h), but also 
the averaged UO values in the first and second week of hospitalization were lower (1.49 vs. 
2.57 ml/kg/h and 1.77 vs. 2.76 ml/kg/h, respectively), with the difference of the minimum 
UO in the first week being statistically significant (p < 0.05). 
Figure 2 presents the Kaplan-Meier survival curves that document the cumulative 
survival ratio (CSR) of AKI patients in PICU depending on the criterion of oliguria presence 
(oliguria being defined as UO <0.5 ml/kg/h/min.16 hours). As it follows from the analysis, 
the final CSR (FCSR) of the patients who had not developed oliguria equaled 49%, while for 
children who had met the oliguria criterion, the respective value was only 37%, with the 
difference being borderline significant (p=0.08 in the log-rank and Cox-Mantel test; p=0.06 
in the Gehan-Wilcoxon test). 
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Figure 3 presents the ROC 
curve plotted for the number 
of deaths as depending on the 
mean value of hourly UO in the 
first week of hospitalization 
in PICU. As it follows from the 
analysis, in the selected cut-
off point of the curve equaling 
1.4 ml/kg/h, the likelihood 
ratio (LR) was 3.75 (at 50% 
sensitivity and 87% specificity). 
This means that the ratio of 
the deceased children to the 
surviving children following 
the application of the condition 
describing the UO value as 
< 1.4 ml/kg/h in comparison 
to the same ratio in the studied 
population increased 3.75 
times. 
As it has been already 
mentioned, the risk of death 
in the studied population 
was 40%, but the same risk 
in children, in whom the 
mean UO in the first week of 
hospitalization in PICU had 
not exceeded 1.4 ml/kg/h was 
71% (PPV=0.71), and thus, the 
risk increased in the patients 
indicated by the test by a factor 
of 1.8. 
The high prognostic value 
of UO was also supported 
by the fact that a difference 
was observed in the oliguria 
criterion as the prerequisite of 
diagnosing AKI (0.5 ml/kg/h/
min. 16 hours – stage I), the 
difference being seen in 70% 
of the subjects in the group 
of the deceased children and 
only in 33% of the surviving 
children. However this 
difference was not reaching 
significance (p=0.08, Fisher’s 
exact test), possibly due to 
the small number of patients. 
Table 5 presents a comparison 
of selected clinical parameters 
of the surviving children vs. the 
deceased patients. 
Fig. 3. The ROC curve plotted for the number of deaths as depend-
ing on the mean urine output value in the first week of hospitaliza-
tion in PICU for all AKI patients; AUROC: 75% for the selected cut-off 
value of 1.4 ml/kg/h, likelihood ratio (LR): 3.75; sensitivity: 50%; 
specificity: 87%. 
Fig. 2. The cumulative survival ratio of patients with AKI in PICU 
depending on the criterion of oliguria presence (defined as urine 
output <0.5 ml/kg/h. / min. 16 hours).
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Table 5. Comparison of selected clinical parameters of the surviving vs. deceased children with AKI
Discussion 
The present study has included such factors as the prevalence, duration of hospitalization 
and mortality rates of patients with AKI, as well as AKI diagnosing based on the pRIFLE scale 
criteria depending on the employed initial value of SCr or eGFR. 
According to various authors, the mean incidence of AKI (diagnosed based on the pRIFLE 
scale criteria) in PICUs falls within a very broad range, from 4.5% [16] to 82% [1] with the 
mean value being 49% (Table 6). In the seven year period of the study the diagnosis of AKI 
(code N17) was established only in 25 cases (1.24% of the total number of PICU patients at 
this period which amounted to 2014), which seems to be a surprisingly low. The presented 
prevalence rate illustrates a situation when the above diagnosis was established monthly 
only in 0.3 patients treated in PICU or when a single case of AKI was diagnosed every 3.36 
months. 
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A significant cause of a low frequency of diagnosing AKI is the fact that over 4 years, 
PICU fulfilled the role of the postoperative unit, what caused an increase in the total number 
of patients. Nevertheless, the undoubtedly dedicated medical staff should be more sensitive 
to the problems and epidemiology of AKI in PICU. Such a low frequency of diagnosing this 
complication may result from the fact that over the seven years in question, renal replacement 
therapy was required by 12 children only. Moreover, physicians are still convinced of the 
importance of maintaining UO, the notion being grossly overemphasized. This has been 
demonstrated in the present study, where the majority of newborns and infants (10/16) 
already diagnosed with AKI still showed normal UO values. The value of hourly UO cannot be 
a reliable marker sufficient to diagnose AKI in the youngest children. Decreased UO starts to 
be of a diagnostics value only in children above 1 year of life which was noted in this study. 
A high importance of modified criteria in diagnosing AKI in the group of newborns was also 
found by Ricci et al. [17] and Bezerra et al. [18], who maintain the position advocating using 
the neonatal RIFLE scale, where the criterion of normal UO has been established as 1.5 ml/
kg/h, and stages R and I begin respectively at UO < 1.5 ml/kg/h/24 hours and < 1.0 ml/
kg/h/24 hours. 
The prevalence of establishing the diagnosis of AKI depending on the employed method 
of assessing the initial kidney function was analyzed in this study. In view of the very low 
number of patients in the studied population, it has not been possible to demonstrate 
differences in the prevalence of diagnosing AKI depending on the method of estimating the 
initial value of eGFR or SCr for the pRIFLE scale (Tab. 4). Irrespectively of the employed 
method, each diagnosed case met the criteria of AKI diagnosis. According to Zappitelli et al. 
[19], various methods of estimating initial eGFR determine the frequency of diagnosing AKI, 
with the percentage values dispersed from 12% to 88%. 
Nevertheless, even with such a limited clinical material in this study - the differences 
were found in the prevalence of diagnosing AKI based on the criterion of hourly urine output 
(UO < 0.5 ml/kg/h/min. 16 hours). The mean prevalence of diagnosing AKI based on the UO 
criterion for the total studied population of children was 48% (Tab. 3, Tab. 4). 
The issue of differences in the prevalence of diagnosing AKI in children hospitalized 
in PICU depending on the employed definition of initial kidney function is widely analyzed 
in the literature on the subject [1, 20]. According to Akan-Arikan et al. [1], who - in case the 
value of SCr from the period up to 3 months prior to admission to PICU had not been available 
- estimated the initial kidney function in 150 children based on the assumption that normal 
GFR equaled 100 ml/min/1.73 sq. m, the prevalence of AKI diagnosed based on the increase 
of SCr (in keeping with the pRIFLE scale) was 47.2%, while when estimations were based 
on urine output, the relevant value was only 17.9%. Similar results were obtained by Plötz 
et al., who adopted the same study conditions as Akan-Arikan et al. [1] in their population 
of 103 children. According to Plötz, the prevalence of AKI diagnosed based on an increase of 
SCr (pRIFLE) was 44.7%, while when based on urine output, the value was only 5.8% [20]. 
The low "diagnostic vigilance" in diagnosing AKI in the analyzed population of children 
as compared to the data from the literature is also supported by the fact that in the present 
Table 6.  AKI incidence, duration of hospitalization and mortality rates of children with AKI  in PICU based 
on the literature and data collected in the present study
 Kidney Blood Press Res 2014;39:28-39
DOI: 10.1159/000355774
Published online: May 09, 2014
© 2014 S. Karger AG, Basel
www.karger.com/kbr 37
Miklaszewska et al.: AKI in PICU
study, as many as 21 children (84%) were classified as stage F and only one child as the earliest 
risk stage (R) and three children as stage I (Tab. 3). Data from the literature addressing this 
issue are somewhat different. 
Zapitelli et al. [21] analyzed a group of 140 children, whose initial kidney function - in 
case the value of SCr from the period up to 3 months prior to admission to PICU had not 
been available - was determined based on the assumption that normal GFR equaled 120 ml/
min/1.73 sq. m. In this study, the prevalence of AKI diagnosed based on a decrease in eGFR in 
keeping with the pRIFLE scale was 75.7%, with 35.7% being at the risk stage R, 22.1% at the 
injury stage I and only 17.9% at the failure stage F. Kavaz et al., who adopted the same study 
assumption, analyzed a group of 189 children, in whom AKI was seen in 35.9% of cases and 
demonstrated the following prevalence of particular pRIFLE stages: R - 7%, I - 18.5% and 
F - 9.6% [22]. In the previously quoted study of Plötz et al., the investigators demonstrated 
that at the general AKI prevalence value of 58%, as many as 52% of children reached the risk 
stage, 37% - the injury stage, and only 11% - the failure stage [20]. According to Washburn et 
al., in the population of 137 children, AKI was noted in 75.2% of patients; with the risk stage 
seen in as many as 36.5% of cases, the injury stage - in 20.4% and the failure stage - only 
in 18.3% of children [23]. In the reports of Bresolin et al. and Hui et al., in whom the initial 
kidney function in case the value of SCr from the period up to 3 months prior to admission 
to PICU had not been available was determined based on the assumption that normal GFR 
equaled 100 ml/min/1.73 sq. m, the analysis included 126 and 140 children, respectively. 
The prevalence of AKI and the prevalence of its particular stages in the above investigations 
was 46% (R - 17.4%, I - 16.7%, F - 11.9%) and 56% (R - 23%, I - 20%, F - 12%), respectively 
[24, 25]. In the majority of the above quoted reports (excluding the papers by Plötz et al. [20]), 
the prevalence rates of particular pRIFLE stages referred to all the hospitalized children, 
nevertheless, a clear tendency towards stages R and I prevailing over stage F could be noted. 
According to particular authors, the mean mortality rate in patients with AKI 
hospitalized in PICU ranges from 8.9% [26] to 55.4% [21] (mean: 28.5%), being from 1.3 
to 12 (mean: 10.2) times higher as compared to the general mortality rate in such units. In 
the presently analyzed group, 40% of the children died, the value being 4.4 times higher as 
compared to the total mortality rate in PICU (in the analyzed period, mortality among the 
children without AKI was 9%; Tab. 6). Such a high mortality rate may result from the fact of 
assigning the N17 code (AKI) only to children with advanced disease, predominantly at the 
failure stage, therefore this study might not have included patients with earlier stages of AKI 
and this may explain the difference of the results in comparison with similar studies. 
A similar conclusion arises following an analysis of the frequency of employing 
mechanical ventilatory support in children with AKI. In the analyzed group, mechanical 
ventilation was required by the mean percentage of 92% of the children, while according to 
various authors, the mean percentage of ventilatory supports in children with AKI ranged 
from 26.7% [26] to 63.8% [24] (mean: 46.3%), although there are reports confirming a 
100% necessity of employing ventilators in the population of children with AKI [1]. 
According to the literature, the mean duration of hospitalization in AKI patients in 
PICU ranges from 9 [27] to 51 days [26] (mean: 25.8 days). In the present study, the mean 
duration of hospitalization in PICU was 35 days, what is consistent with literature data on 
the length of hospitalization in PICU for AKI patients. In regard to patients without AKI 
according to particular authors - their mean PICU hospitalization time ranges from 2 [27] 
to 23.2 [24] (mean: 12) days, being from 0.86 [20] to 2.8 [26] (mean: 2,3) times shorter as 
compared to the PICU length of stay of patients with AKI. In the presently analyzed group, 
the PICU hospitalization duration of patients without AKI lasted 9.6 days being 3.6 times 
shorter comparing to PICU duration of hospitalization of AKI patients, which is statistically 
significant (p<0.05, Tab. 6). 
Having performed our analysis exercising due diligence during the stage of material 
collection and statistical analysis of our results, we see the weak points of our study. We realize 
the study included a relatively small number of patients. In addition, it was retrospective and 
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